Researcher.Life Logo

Medical Oncology : Impact Factor & More

eISSN: 1559-131XpISSN: 1357-0560

Key Metrics

CiteScore
5.1
H-Index
87
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.98
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Medical Oncology

Medical Oncology Journal Specifications

Overview
Publisher HUMANA PRESS INC
Language English
Frequency Continuous publication
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year1984
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Medical Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Medical Oncology

Site-specific trastuzumab Fab-DM1 via butelase-1 with ABD fusion for potent HER2-positive tumor control.
  • 1 Jul 2026
  • Medical oncology (Northwood, London, England)
DC-intrinsic SHP1 restrains central memory CD8⁺ T cell formation via the TCF-1/Wnt/β-Catenin axis.
  • 1 Jul 2026
  • Medical oncology (Northwood, London, England)
Novel patient-derived tongue squamous cell carcinoma cell lines from non-smokers: 3D and in vivo models for drug response studies.
  • 29 Jun 2026
  • Medical oncology (Northwood, London, England)
Unraveling the link between genomic instability and tumor immune evasion in oral squamous cell carcinoma: Role of CBMN assay and emerging perspectives.
  • 29 Jun 2026
  • Medical oncology (Northwood, London, England)
Decoy oligonucleotide technology in cancer therapy: molecular mechanisms, challenges, and translational potential.
  • 29 Jun 2026
  • Medical oncology (Northwood, London, England)
The translational roles of circular RNAs in cancers and their underlying molecular mechanisms.
  • 27 Jun 2026
  • Medical oncology (Northwood, London, England)
Site-specific trastuzumab Fab-DM1 via butelase-1 with ABD fusion for potent HER2-positive tumor control.
  • 1 Jul 2026
  • Medical oncology (Northwood, London, England)
DC-intrinsic SHP1 restrains central memory CD8⁺ T cell formation via the TCF-1/Wnt/β-Catenin axis.
  • 1 Jul 2026
  • Medical oncology (Northwood, London, England)
Novel patient-derived tongue squamous cell carcinoma cell lines from non-smokers: 3D and in vivo models for drug response studies.
  • 29 Jun 2026
  • Medical oncology (Northwood, London, England)
Unraveling the link between genomic instability and tumor immune evasion in oral squamous cell carcinoma: Role of CBMN assay and emerging perspectives.
  • 29 Jun 2026
  • Medical oncology (Northwood, London, England)
Decoy oligonucleotide technology in cancer therapy: molecular mechanisms, challenges, and translational potential.
  • 29 Jun 2026
  • Medical oncology (Northwood, London, England)
The translational roles of circular RNAs in cancers and their underlying molecular mechanisms.
  • 27 Jun 2026
  • Medical oncology (Northwood, London, England)

FAQs on Medical Oncology